<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38837378</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>An efficient <i>trans</i> complementation system for <i>in vivo</i> replication of defective poliovirus mutants.</ArticleTitle><Pagination><StartPage>e0052324</StartPage><MedlinePgn>e0052324</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00523-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00523-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">The picornavirus genome encodes a large, single polyprotein that is processed by viral proteases to form an active replication complex. The replication complex is formed with the viral genome, host proteins, and viral proteins that are produced/translated directly from each of the viral genomes (viral proteins provided in <i>cis</i>). Efficient complementation <i>in vivo</i> of replication complex formation by viral proteins provided in <i>trans</i>, thus exogenous or ectopically expressed viral proteins, remains to be demonstrated. Here, we report an efficient <i>trans</i> complementation system for the replication of defective poliovirus (PV) mutants by a viral polyprotein precursor in HEK293 cells. Viral 3AB in the polyprotein, but not 2BC, was processed exclusively in <i>cis</i>. Replication of a defective PV replicon mutant, with a disrupted cleavage site for viral 3C<sup>pro</sup> protease between 3C<sup>pro</sup> and 3D<sup>pol</sup> (3C/D[A/G] mutant) could be rescued by a viral polyprotein provided in <i>trans</i>. Only a defect of 3D<sup>pol</sup> activity of the replicon could be rescued in <i>trans</i>; inactivating mutations in 2C<sup>ATPase/hel</sup>, 3B, and 3C<sup>pro</sup> of the replicon completely abrogated the <i>trans</i>-rescued replication. An intact N-terminus of the 3C<sup>pro</sup> domain of the 3CD<sup>pro</sup> provided in <i>trans</i> was essential for the <i>trans</i>-active function. By using this <i>trans</i> complementation system, a high-titer defective PV pseudovirus (PV<sub>pv</sub>) (&gt;10<sup>7</sup> infectious units per mL) could be produced with the defective mutants, whose replication was completely dependent on <i>trans</i> complementation. This work reveals potential roles of exogenous viral proteins in PV replication and offers insights into protein/protein interaction during picornavirus infection.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Viral polyprotein processing is an elaborately controlled step by viral proteases encoded in the polyprotein; fully processed proteins and processing intermediates need to be correctly produced for replication, which can be detrimentally affected even by a small modification of the polyprotein. Purified/isolated viral proteins can retain their enzymatic activities required for viral replication, such as protease, helicase, polymerase, etc. However, when these proteins of picornavirus are exogenously provided (provided in <i>trans</i>) to the viral replication complex with a defective viral genome, replication is generally not rescued/complemented, suggesting the importance of viral proteins endogenously provided (provided in <i>cis</i>) to the replication complex. In this study, I discovered that only the viral polymerase activity of poliovirus (PV) (the typical member of picornavirus family) could be efficiently rescued by exogenously expressed viral proteins. The current study reveals potential roles for exogenous viral proteins in viral replication and offers insights into interactions during picornavirus infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Minetaro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3314-6626</Identifier><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>23fk0108627j0002</GrantID><Agency>Japan Agency for Medical Research and Development (AMED)</Agency><Country /></Grant><Grant><GrantID>22K07107</GrantID><Agency>MEXT | Japan Society for the Promotion of Science (JSPS)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020815">Polyproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="Y">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005816" MajorTopicYN="N">Genetic Complementation Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020815" MajorTopicYN="N">Polyproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">trans complementation</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38837378</ArticleId><ArticleId IdType="pmc">PMC11265389</ArticleId><ArticleId IdType="doi">10.1128/jvi.00523-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547–553. doi:10.1038/291547a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/291547a0</ArticleId><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lulla V, Dinan AM, Hosmillo M, Chaudhry Y, Sherry L, Irigoyen N, Nayak KM, Stonehouse NJ, Zilbauer M, Goodfellow I, Firth AE. 2019. An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells. Nat Microbiol 4:280–292. doi:10.1038/s41564-018-0297-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0297-1</ArticleId><ArticleId IdType="pmc">PMC6443042</ArticleId><ArticleId IdType="pubmed">30478287</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H, Nicklin MJ, Murray MG, Anderson CW, Dunn JJ, Studier FW, Wimmer E. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761–770. doi:10.1016/0092-8674(86)90790-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90790-7</ArticleId><ArticleId IdType="pubmed">3011278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL. 1988. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166:265–270. doi:10.1016/0042-6822(88)90172-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(88)90172-9</ArticleId><ArticleId IdType="pubmed">2842953</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Peersen O. 2023. Co-folding and RNA activation of poliovirus 3Cpro polyprotein precursors. J Biol Chem 299:105258. doi:10.1016/j.jbc.2023.105258</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.105258</ArticleId><ArticleId IdType="pmc">PMC10590986</ArticleId><ArticleId IdType="pubmed">37717698</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Wang P, Wang GC, Yang J, Sun X, Wu W, Qiu Y, Shu T, Zhao X, Yin L, Qin CF, Hu Y, Zhou X. 2015. Human enterovirus nonstructural protein 2CATPase functions as both an RNA helicase and ATP-independent RNA chaperone. PLoS Pathog 11:e1005067. doi:10.1371/journal.ppat.1005067</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005067</ArticleId><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieva JL, Madan V, Carrasco L. 2012. Viroporins: structure and biological functions. Nat Rev Microbiol 10:563–574. doi:10.1038/nrmicro2820</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2820</ArticleId><ArticleId IdType="pmc">PMC7097105</ArticleId><ArticleId IdType="pubmed">22751485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeager C, Carter G, Gohara DW, Yennawar NH, Enemark EJ, Arnold JJ, Cameron CE. 2022. Enteroviral 2C protein is an RNA-stimulated ATPase and uses a two-step mechanism for binding to RNA and ATP. Nucleic Acids Res 50:11775–11798. doi:10.1093/nar/gkac1054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1054</ArticleId><ArticleId IdType="pmc">PMC9723501</ArticleId><ArticleId IdType="pubmed">36399514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. 2010. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6:e1001066. doi:10.1371/journal.ppat.1001066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kuppeveld FJ, Hoenderop JG, Smeets RL, Willems PH, Dijkman HB, Galama JM, Melchers WJ. 1997. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J 16:3519–3532. doi:10.1093/emboj/16.12.3519</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/16.12.3519</ArticleId><ArticleId IdType="pmc">PMC1169977</ArticleId><ArticleId IdType="pubmed">9218794</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomoto A, Detjen B, Pozzatti R, Wimmer E. 1977. The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature 268:208–213. doi:10.1038/268208a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/268208a0</ArticleId><ArticleId IdType="pubmed">196204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki J, Ishikawa K, Arita M, Taniguchi K. 2012. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J 31:754–766. doi:10.1038/emboj.2011.429</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.429</ArticleId><ArticleId IdType="pmc">PMC3273392</ArticleId><ArticleId IdType="pubmed">22124328</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Knudsen GM, Betegon M, Burlingame AL, Derisi JL. 2012. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIbeta. J Virol 86:3605–3616. doi:10.1128/JVI.06778-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06778-11</ArticleId><ArticleId IdType="pmc">PMC3302542</ArticleId><ArticleId IdType="pubmed">22258260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Niu T-K, Neumann S, Oorschot VM, de Lange F, Lanke KHW, Klumperman J, Henke A, Jackson CL, Melchers WJG, van Kuppeveld FJM. 2006. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 11:191–201. doi:10.1016/j.devcel.2006.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.06.005</ArticleId><ArticleId IdType="pubmed">16890159</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E. 2008. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog 4:e1000216. doi:10.1371/journal.ppat.1000216</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000216</ArticleId><ArticleId IdType="pmc">PMC2581890</ArticleId><ArticleId IdType="pubmed">19023417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJM, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799–811. doi:10.1016/j.cell.2010.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.050</ArticleId><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu CM, van der Schaar HM, Ford LA, Strating J, Ulferts R, Fang Y, Belov G, van Kuppeveld FJM. 2014. Recruitment of PI4KIIIbeta to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J Virol 88:2725–2736. doi:10.1128/JVI.03650-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03650-13</ArticleId><ArticleId IdType="pmc">PMC3958084</ArticleId><ArticleId IdType="pubmed">24352456</ArticleId></ArticleIdList></Reference><Reference><Citation>Takegami T, Semler BL, Anderson CW, Wimmer E. 1983. Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology 128:33–47. doi:10.1016/0042-6822(83)90316-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(83)90316-1</ArticleId><ArticleId IdType="pubmed">6308897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch MA, Kew OM, Semler BL, Omilianowski DR, Anderson CW, Wimmer E, Rueckert RR. 1984. Protein processing map of poliovirus. J Virol 49:873–880. doi:10.1128/JVI.49.3.873-880.1984</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.49.3.873-880.1984</ArticleId><ArticleId IdType="pmc">PMC255549</ArticleId><ArticleId IdType="pubmed">6321771</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhy DA, Giddings Jr TH, Kirkegaard K. 2000. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 74:8953–8965. doi:10.1128/jvi.74.19.8953-8965.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.19.8953-8965.2000</ArticleId><ArticleId IdType="pmc">PMC102091</ArticleId><ArticleId IdType="pubmed">10982339</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Cao X, Harris KS, Lama J, Wimmer E. 1994. Studies with poliovirus polymerase 3Dpol. Stimulation of poly(U) synthesis in vitro by purified poliovirus protein 3AB. J Biol Chem 269:29173–29181. doi:10.1016/S0021-9258(19)62027-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)62027-2</ArticleId><ArticleId IdType="pubmed">7961883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lama J, Paul AV, Harris KS, Wimmer E. 1994. Properties of purified recombinant poliovirus protein 3AB as substrate for viral proteinases and as co-factor for RNA polymerase 3Dpol. J Biol Chem 269:66–70. doi:10.1016/S0021-9258(17)42314-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)42314-3</ArticleId><ArticleId IdType="pubmed">8276867</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards OC, Ehrenfeld E. 1998. Effects of poliovirus 3AB protein on 3D polymerase-catalyzed reaction. J Biol Chem 273:12832–12840. doi:10.1074/jbc.273.21.12832</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.21.12832</ArticleId><ArticleId IdType="pubmed">9582311</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R, Rieckhof GE, Achacoso PL, Baltimore D. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J 12:3587–3598. doi:10.1002/j.1460-2075.1993.tb06032.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06032.x</ArticleId><ArticleId IdType="pmc">PMC413634</ArticleId><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamarnik AV, Andino R. 1998. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev 12:2293–2304. doi:10.1101/gad.12.15.2293</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.12.15.2293</ArticleId><ArticleId IdType="pmc">PMC317040</ArticleId><ArticleId IdType="pubmed">9694795</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E. 2000. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol 74:10359–10370. doi:10.1128/JVI.74.22.10359-10370.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.22.10359-10370.2000</ArticleId><ArticleId IdType="pmc">PMC110910</ArticleId><ArticleId IdType="pubmed">11044080</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Mugavero J, Molla A, Wimmer E. 1998. Internal ribosomal entry site scanning of the poliovirus polyprotein: implications for proteolytic processing. Virology 250:241–253. doi:10.1006/viro.1998.9376</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1998.9376</ArticleId><ArticleId IdType="pubmed">9770438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole CN, Smoler D, Wimmer E, Baltimore D. 1971. Defective interfering particles of poliovirus. I. Isolation and physical properties. J Virol 7:478–485. doi:10.1128/JVI.7.4.478-485.1971</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.7.4.478-485.1971</ArticleId><ArticleId IdType="pmc">PMC356147</ArticleId><ArticleId IdType="pubmed">4329564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuge S, Saito I, Nomoto A. 1986. Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol 192:473–487. doi:10.1016/0022-2836(86)90270-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(86)90270-6</ArticleId><ArticleId IdType="pubmed">3031313</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak JE, Kirkegaard K. 1994. Coupling between genome translation and replication in an RNA virus. Genes Dev 8:1726–1737. doi:10.1101/gad.8.14.1726</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.8.14.1726</ArticleId><ArticleId IdType="pubmed">7958852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn RJ, Tada H, Ypma-Wong MF, Semler BL, Wimmer E. 1988. Mutational analysis of the genome-linked protein VPg of poliovirus. J Virol 62:4207–4215. doi:10.1128/JVI.62.11.4207-4215.1988</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.11.4207-4215.1988</ArticleId><ArticleId IdType="pmc">PMC253853</ArticleId><ArticleId IdType="pubmed">2845132</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Molla A, Wimmer E. 1994. Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology 199:188–199. doi:10.1006/viro.1994.1111</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1111</ArticleId><ArticleId IdType="pubmed">8116242</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Lu HH, Mueller S, Wimmer E. 2001. The C-terminal residues of poliovirus proteinase 2Apro are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. J Gen Virol 82:397–408. doi:10.1099/0022-1317-82-2-397</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-2-397</ArticleId><ArticleId IdType="pubmed">11161279</ArticleId></ArticleIdList></Reference><Reference><Citation>Herod MR, Gold S, Lasecka-Dykes L, Wright C, Ward JC, McLean TC, Forrest S, Jackson T, Tuthill TJ, Rowlands DJ, Stonehouse NJ. 2017. Genetic economy in picornaviruses: foot-and-mouth disease virus replication exploits alternative precursor cleavage pathways. PLoS Pathog 13:e1006666. doi:10.1371/journal.ppat.1006666</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006666</ArticleId><ArticleId IdType="pmc">PMC5638621</ArticleId><ArticleId IdType="pubmed">28968463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce DM, Hayward C, Rowlands DJ, Stonehouse NJ, Herod MR. 2023. Insights into polyprotein processing and RNA-protein interactions in foot-and-mouth disease virus genome replication. J Virol 97:e0017123. doi:10.1128/jvi.00171-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00171-23</ArticleId><ArticleId IdType="pmc">PMC10231256</ArticleId><ArticleId IdType="pubmed">37154761</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Kojima H, Nagano T, Okabe T, Wakita T, Shimizu H. 2013. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. J Virol 87:4252–4260. doi:10.1128/JVI.03546-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03546-12</ArticleId><ArticleId IdType="pmc">PMC3624399</ArticleId><ArticleId IdType="pubmed">23365445</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. 2016. Mechanism of poliovirus resistance to host phosphatidylinositol-4 kinase III β inhibitor. ACS Infect Dis 2:140–148. doi:10.1021/acsinfecdis.5b00122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.5b00122</ArticleId><ArticleId IdType="pubmed">27624965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo H, Dorobantu CM, van der Schaar HM, van Kuppeveld FJM. 2017. Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIbeta or oxysterol binding protein. Antiviral Res 147:86–90. doi:10.1016/j.antiviral.2017.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.10.006</ArticleId><ArticleId IdType="pubmed">29024767</ArticleId></ArticleIdList></Reference><Reference><Citation>Melia CE, van der Schaar HM, Lyoo H, Limpens RWAL, Feng Q, Wahedi M, Overheul GJ, van Rij RP, Snijder EJ, Koster AJ, Bárcena M, van Kuppeveld FJM. 2017. Escaping host factor PI4KB inhibition: enterovirus genomic RNA replication in the absence of replication organelles. Cell Rep 21:587–599. doi:10.1016/j.celrep.2017.09.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.068</ArticleId><ArticleId IdType="pmc">PMC5656745</ArticleId><ArticleId IdType="pubmed">29045829</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Bigay J. 2019. Poliovirus evolution toward independence from the phosphatidylinositol-4 kinase III beta/oxysterol-binding protein family I pathway. ACS Infect Dis 5:962–973. doi:10.1021/acsinfecdis.9b00038</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.9b00038</ArticleId><ArticleId IdType="pubmed">30919621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishitsuka H, Ohsawa C, Ohiwa T, Umeda I, Suhara Y. 1982. Antipicornavirus flavone Ro 09-0179. Antimicrob Agents Chemother 22:611–616. doi:10.1128/AAC.22.4.611</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.22.4.611</ArticleId><ArticleId IdType="pmc">PMC183801</ArticleId><ArticleId IdType="pubmed">6295260</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz BA, Vance LM. 1995. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J Virol 69:4189–4197. doi:10.1128/JVI.69.7.4189-4197.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.7.4189-4197.1995</ArticleId><ArticleId IdType="pmc">PMC189156</ArticleId><ArticleId IdType="pubmed">7769678</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. 2014. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol Immunol 58:239–256. doi:10.1111/1348-0421.12144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12144</ArticleId><ArticleId IdType="pubmed">24527995</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. 2021. High-order epistasis and functional coupling of infection steps drive virus evolution toward independence from a host pathway. Microbiol Spectr 9:e0080021. doi:10.1128/Spectrum.00800-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00800-21</ArticleId><ArticleId IdType="pmc">PMC8557862</ArticleId><ArticleId IdType="pubmed">34468191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikel JH, Paget CJ, DeLong DC, Nelson JD, Wu CY, Paschal JW, Dinner A, Templeton RJ, Chaney MO, Jones ND, Chamberlin JW. 1980. Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidaz ol-2-amine. Inhibitors of rhinovirus multiplication. J Med Chem 23:368–372. doi:10.1021/jm00178a004</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm00178a004</ArticleId><ArticleId IdType="pubmed">6247489</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Kojima H, Nagano T, Okabe T, Wakita T, Shimizu H. 2011. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol 85:2364–2372. doi:10.1128/JVI.02249-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02249-10</ArticleId><ArticleId IdType="pmc">PMC3067798</ArticleId><ArticleId IdType="pubmed">21177810</ArticleId></ArticleIdList></Reference><Reference><Citation>Delang L, Paeshuyse J, Neyts J. 2012. The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication. Biochem Pharmacol 84:1400–1408. doi:10.1016/j.bcp.2012.07.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2012.07.034</ArticleId><ArticleId IdType="pmc">PMC7111036</ArticleId><ArticleId IdType="pubmed">22885339</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLeod AM, Mitchell DR, Palmer NJ, Van de Poël H, Conrath K, Andrews M, Leyssen P, Neyts J. 2013. Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections. ACS Med Chem Lett 4:585–589. doi:10.1021/ml400095m</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ml400095m</ArticleId><ArticleId IdType="pmc">PMC4030314</ArticleId><ArticleId IdType="pubmed">24900715</ArticleId></ArticleIdList></Reference><Reference><Citation>Strating J, van der Linden L, Albulescu L, Bigay J, Arita M, Delang L, Leyssen P, van der Schaar HM, Lanke KHW, Thibaut HJ, Ulferts R, Drin G, Schlinck N, Wubbolts RW, Sever N, Head SA, Liu JO, Beachy PA, De Matteis MA, Shair MD, Olkkonen VM, Neyts J, van Kuppeveld FJM. 2015. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep 10:600–615. doi:10.1016/j.celrep.2014.12.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.054</ArticleId><ArticleId IdType="pmc">PMC4383725</ArticleId><ArticleId IdType="pubmed">25640182</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T, Fujita M, Ishibashi Y, Nomanbhoy T, Rosenblum JS, Nagasawa M. 2021. 134. KRP-A218, an orally active and selective PI4KB inhibitor with broad-spectrum anti-rhinovirus activity, has potent therapeutic antiviral activity in vivo. Open Forum Infect Dis 8:S82–S82. doi:10.1093/ofid/ofab466.134</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab466.134</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler BL, Anderson CW, Hanecak R, Dorner LF, Wimmer E. 1982. A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell 28:405–412. doi:10.1016/0092-8674(82)90358-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(82)90358-0</ArticleId><ArticleId IdType="pubmed">6277514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi J, Arita M, Sakai S, Kojima H, Senda M, Senda T, Hanada K, Kato R. 2022. Ligand recognition by the lipid transfer domain of human OSBP is important for enterovirus replication. ACS Infect Dis 8:1161–1170. doi:10.1021/acsinfecdis.2c00108</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.2c00108</ArticleId><ArticleId IdType="pubmed">35613096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Lovell S, Tiew K-C, Mandadapu SR, Alliston KR, Battaile KP, Groutas WC, Chang K-O. 2012. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol 86:11754–11762. doi:10.1128/JVI.01348-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01348-12</ArticleId><ArticleId IdType="pmc">PMC3486288</ArticleId><ArticleId IdType="pubmed">22915796</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A 96:11000–11007. doi:10.1073/pnas.96.20.11000</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.20.11000</ArticleId><ArticleId IdType="pmc">PMC34232</ArticleId><ArticleId IdType="pubmed">10500114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kräusslich HG, Nicklin MJ, Lee CK, Wimmer E. 1988. Polyprotein processing in picornavirus replication. Biochimie 70:119–130. doi:10.1016/0300-9084(88)90166-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-9084(88)90166-6</ArticleId><ArticleId IdType="pubmed">2840974</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, Nurminen A, Hytönen VP, Flodström-Tullberg M. 2016. Enteroviral proteases: structure, host interactions and pathogenicity. Rev Med Virol 26:251–267. doi:10.1002/rmv.1883</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi H, Yoshino Y, Miyazawa M, Horie H, Ohka S, Nomoto A. 2010. 2A protease is not a prerequisite for poliovirus replication. J Virol 84:5947–5957. doi:10.1128/JVI.02575-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-09</ArticleId><ArticleId IdType="pmc">PMC2876632</ArticleId><ArticleId IdType="pubmed">20392856</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuer Q, Kuhn RJ, Wimmer E. 1990. Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J Virol 64:2967–2975. doi:10.1128/JVI.64.6.2967-2975.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.64.6.2967-2975.1990</ArticleId><ArticleId IdType="pmc">PMC249481</ArticleId><ArticleId IdType="pubmed">2159557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hämmerle T, Hellen CU, Wimmer E. 1991. Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinase. J Biol Chem 266:5412–5416. doi:10.1016/S0021-9258(19)67610-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)67610-6</ArticleId><ArticleId IdType="pubmed">1848550</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablonski SA, Morrow CD. 1995. Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity. J Virol 69:1532–1539. doi:10.1128/JVI.69.3.1532-1539.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.3.1532-1539.1995</ArticleId><ArticleId IdType="pmc">PMC188746</ArticleId><ArticleId IdType="pubmed">7853486</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AA, Peersen OB. 2004. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J 23:3462–3471. doi:10.1038/sj.emboj.7600357</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600357</ArticleId><ArticleId IdType="pmc">PMC516629</ArticleId><ArticleId IdType="pubmed">15306852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shengjuler D, Chan YM, Sun S, Moustafa IM, Li ZL, Gohara DW, Buck M, Cremer PS, Boehr DD, Cameron CE. 2017. The RNA-binding site of poliovirus 3C protein doubles as a phosphoinositide-binding domain. Structure 25:1875–1886. doi:10.1016/j.str.2017.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC5728361</ArticleId><ArticleId IdType="pubmed">29211985</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair WS, Parsley TB, Bogerd HP, Towner JS, Semler BL, Cullen BR. 1998. Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA 4:215–225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369610</ArticleId><ArticleId IdType="pubmed">9570321</ArticleId></ArticleIdList></Reference><Reference><Citation>Amero CD, Arnold JJ, Moustafa IM, Cameron CE, Foster MP. 2008. Identification of the oriI-binding site of poliovirus 3C protein by nuclear magnetic resonance spectroscopy. J Virol 82:4363–4370. doi:10.1128/JVI.02087-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02087-07</ArticleId><ArticleId IdType="pmc">PMC2293054</ArticleId><ArticleId IdType="pubmed">18305026</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Nagata N, Sata T, Miyamura T, Shimizu H. 2006. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J Gen Virol 87:3317–3327. doi:10.1099/vir.0.82172-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82172-0</ArticleId><ArticleId IdType="pubmed">17030866</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Iwai-Itamochi M. 2019. Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test. Sci Rep 9:11970. doi:10.1038/s41598-019-48534-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48534-1</ArticleId><ArticleId IdType="pmc">PMC6700111</ArticleId><ArticleId IdType="pubmed">31427704</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Iwai M, Wakita T, Shimizu H. 2011. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol 18:1889–1894. doi:10.1128/CVI.05225-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.05225-11</ArticleId><ArticleId IdType="pmc">PMC3209023</ArticleId><ArticleId IdType="pubmed">21880850</ArticleId></ArticleIdList></Reference><Reference><Citation>Charini WA, Burns CC, Ehrenfeld E, Semler BL. 1991. trans rescue of a mutant poliovirus RNA polymerase function. J Virol 65:2655–2665. doi:10.1128/JVI.65.5.2655-2665.1991</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.65.5.2655-2665.1991</ArticleId><ArticleId IdType="pmc">PMC240624</ArticleId><ArticleId IdType="pubmed">1850039</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina NL, Zhou WD, Cho MW, Ehrenfeld E. 1995. Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol 69:4245–4254. doi:10.1128/JVI.69.7.4245-4254.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.7.4245-4254.1995</ArticleId><ArticleId IdType="pmc">PMC189162</ArticleId><ArticleId IdType="pubmed">7769684</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Wimmer E. 1995. Intragenomic complementation of a 3AB mutant in dicistronic polioviruses. Virology 209:315–326. doi:10.1006/viro.1995.1263</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1263</ArticleId><ArticleId IdType="pubmed">7778266</ArticleId></ArticleIdList></Reference><Reference><Citation>Towner JS, Mazanet MM, Semler BL. 1998. Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins. J Virol 72:7191–7200. doi:10.1128/JVI.72.9.7191-7200.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7191-7200.1998</ArticleId><ArticleId IdType="pmc">PMC109941</ArticleId><ArticleId IdType="pubmed">9696813</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Franco D, Paul AV, Wimmer E. 2007. Tyrosine 3 of poliovirus terminal peptide VPg(3B) has an essential function in RNA replication in the context of its precursor protein, 3AB. J Virol 81:5669–5684. doi:10.1128/JVI.02350-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02350-06</ArticleId><ArticleId IdType="pmc">PMC1900252</ArticleId><ArticleId IdType="pubmed">17360746</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu HH, Li X, Cuconati A, Wimmer E. 1995. Analysis of picornavirus 2Apro proteins: separation of proteinase from translation and replication functions. J Virol 69:7445–7452. doi:10.1128/JVI.69.12.7445-7452.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.12.7445-7452.1995</ArticleId><ArticleId IdType="pmc">PMC189682</ArticleId><ArticleId IdType="pubmed">7494250</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, Barclay W, Evans DJ. 2000. Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74:4590–4600. doi:10.1128/jvi.74.10.4590-4600.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.10.4590-4600.2000</ArticleId><ArticleId IdType="pmc">PMC111979</ArticleId><ArticleId IdType="pubmed">10775595</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JQ, Townsend HL, Jha BK, Paranjape JM, Silverman RH, Barton DJ. 2007. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 81:5561–5572. doi:10.1128/JVI.01857-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01857-06</ArticleId><ArticleId IdType="pmc">PMC1900262</ArticleId><ArticleId IdType="pubmed">17344297</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend HL, Jha BK, Han JQ, Maluf NK, Silverman RH, Barton DJ. 2008. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA 14:1026–1036. doi:10.1261/rna.958908</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.958908</ArticleId><ArticleId IdType="pmc">PMC2390801</ArticleId><ArticleId IdType="pubmed">18426919</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Liu Y, Ward CB, Mueller S, Futcher B, Skiena S, Paul AV, Wimmer E. 2012. Identification of two functionally redundant RNA elements in the coding sequence of poliovirus using computer-generated design. Proc Natl Acad Sci U S A 109:14301–14307. doi:10.1073/pnas.1211484109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1211484109</ArticleId><ArticleId IdType="pmc">PMC3437848</ArticleId><ArticleId IdType="pubmed">22886087</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrill CP, Westesson O, Schulte MB, Strings VR, Segal M, Andino R. 2013. Global RNA structure analysis of poliovirus identifies a conserved RNA structure involved in viral replication and infectivity. J Virol 87:11670–11683. doi:10.1128/JVI.01560-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01560-13</ArticleId><ArticleId IdType="pmc">PMC3807356</ArticleId><ArticleId IdType="pubmed">23966409</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Yin J, Mugavero J, Rieder E, Liu Y, Wimmer E. 2003. A "slide-back" mechanism for the initiation of protein-primed RNA synthesis by the RNA polymerase of poliovirus. J Biol Chem 278:43951–43960. doi:10.1074/jbc.M307441200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M307441200</ArticleId><ArticleId IdType="pubmed">12937178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell YC, Semler BL, Ehrenfeld E. 1999. Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J Virol 73:9413–9421. doi:10.1128/JVI.73.11.9413-9421.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.11.9413-9421.1999</ArticleId><ArticleId IdType="pmc">PMC112976</ArticleId><ArticleId IdType="pubmed">10516050</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kuppeveld FJM, van den Hurk P, Schrama IWJ, Galama JMD, Melchers WJG. 2002. Trans-complementation of a genetic defect in the coxsackie B3 virus 2B protein. J Gen Virol 83:341–350. doi:10.1099/0022-1317-83-2-341</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-2-341</ArticleId><ArticleId IdType="pubmed">11807227</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ooij MJM, Vogt DA, Paul A, Castro C, Kuijpers J, van Kuppeveld FJM, Cameron CE, Wimmer E, Andino R, Melchers WJG. 2006. Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis. J Gen Virol 87:103–113. doi:10.1099/vir.0.81297-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81297-0</ArticleId><ArticleId IdType="pubmed">16361422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Lin Q, Wang C, Xing J, Yan K, Liu Z, Jin Y, Cardona CJ, Xing Z. 2021. Enterovirus A71 2B inhibits interferon-activated JAK/STAT signaling by inducing caspase-3-dependent karyopherin-Alpha1 degradation. Front Microbiol 12:762869. doi:10.3389/fmicb.2021.762869</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.762869</ArticleId><ArticleId IdType="pmc">PMC8725996</ArticleId><ArticleId IdType="pubmed">34992585</ArticleId></ArticleIdList></Reference><Reference><Citation>H L, Kumar Ganji V, Elango S, Krishnaswamy N, V U, Reddy GR, Sanyal A, Hj D. 2021. Expression of foot-and-mouth disease virus non-structural protein 3A upregulates the expression of autophagy and immune response genes in vitro. Virus Res 292:198247. doi:10.1016/j.virusres.2020.198247</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198247</ArticleId><ArticleId IdType="pubmed">33253718</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco A, Feduchi E, Carrasco L. 2000. Poliovirus protease 3Cpro kills cells by apoptosis. Virology 266:352–360. doi:10.1006/viro.1999.0043</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.0043</ArticleId><ArticleId IdType="pubmed">10639321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez NM, Van Eden ME, Younan P, Lloyd RE. 2004. Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol Cell Biol 24:1779–1790. doi:10.1128/MCB.24.4.1779-1790.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.4.1779-1790.2004</ArticleId><ArticleId IdType="pmc">PMC344173</ArticleId><ArticleId IdType="pubmed">14749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein MA, Richards OC, Amin C, Ehrenfeld E. 1988. Enzymatic activity of poliovirus RNA polymerase synthesized in Escherichia coli from viral cDNA. Virology 164:301–308. doi:10.1016/0042-6822(88)90542-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(88)90542-9</ArticleId><ArticleId IdType="pubmed">2835852</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KS, Reddigari SR, Nicklin MJ, Hämmerle T, Wimmer E. 1992. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J Virol 66:7481–7489. doi:10.1128/JVI.66.12.7481-7489.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.12.7481-7489.1992</ArticleId><ArticleId IdType="pmc">PMC240456</ArticleId><ArticleId IdType="pubmed">1331532</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh HS, Pathak HB, Goodfellow IG, Arnold JJ, Cameron CE. 2009. Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants. J Virol 83:9370–9387. doi:10.1128/JVI.02076-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02076-08</ArticleId><ArticleId IdType="pmc">PMC2738245</ArticleId><ArticleId IdType="pubmed">19587035</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll AR, Rowlands DJ, Clarke BE. 1984. The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res 12:2461–2472. doi:10.1093/nar/12.5.2461</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/12.5.2461</ArticleId><ArticleId IdType="pmc">PMC318676</ArticleId><ArticleId IdType="pubmed">6324120</ArticleId></ArticleIdList></Reference><Reference><Citation>Forss S, Strebel K, Beck E, Schaller H. 1984. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12:6587–6601. doi:10.1093/nar/12.16.6587</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/12.16.6587</ArticleId><ArticleId IdType="pmc">PMC320098</ArticleId><ArticleId IdType="pubmed">6089122</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan TG, Kapusinszky B, Wang C, Rose RK, Lipton HL, Delwart EL. 2011. The fecal viral flora of wild rodents. PLoS Pathog 7:e1002218. doi:10.1371/journal.ppat.1002218</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002218</ArticleId><ArticleId IdType="pmc">PMC3164639</ArticleId><ArticleId IdType="pubmed">21909269</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Kuhn RJ, Wimmer E. 1993. Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J Virol 67:5572–5578. doi:10.1128/JVI.67.9.5572-5578.1993</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.67.9.5572-5578.1993</ArticleId><ArticleId IdType="pmc">PMC237960</ArticleId><ArticleId IdType="pubmed">8394461</ArticleId></ArticleIdList></Reference><Reference><Citation>Berryman S, Moffat K, Harak C, Lohmann V, Jackson T. 2016. Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases. J Gen Virol 97:1841–1852. doi:10.1099/jgv.0.000485</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000485</ArticleId><ArticleId IdType="pmc">PMC5156328</ArticleId><ArticleId IdType="pubmed">27093462</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, Paul AV. 2005. Stimulation of poliovirus RNA synthesis and virus maturation in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. Virol J 2:86. doi:10.1186/1743-422X-2-86</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-2-86</ArticleId><ArticleId IdType="pmc">PMC1315353</ArticleId><ArticleId IdType="pubmed">16300678</ArticleId></ArticleIdList></Reference><Reference><Citation>Spear A, Ogram SA, Morasco BJ, Smerage LE, Flanegan JB. 2015. Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex. Virology 485:492–501. doi:10.1016/j.virol.2015.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.07.018</ArticleId><ArticleId IdType="pmc">PMC4780368</ArticleId><ArticleId IdType="pubmed">26303005</ArticleId></ArticleIdList></Reference><Reference><Citation>Percy N, Barclay WS, Sullivan M, Almond JW. 1992. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J Virol 66:5040–5046. doi:10.1128/JVI.66.8.5040-5046.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.8.5040-5046.1992</ArticleId><ArticleId IdType="pmc">PMC241362</ArticleId><ArticleId IdType="pubmed">1321286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagino-Yamagishi K, Nomoto A. 1989. In vitro construction of poliovirus defective interfering particles. J Virol 63:5386–5392. doi:10.1128/JVI.63.12.5386-5392.1989</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.63.12.5386-5392.1989</ArticleId><ArticleId IdType="pmc">PMC251205</ArticleId><ArticleId IdType="pubmed">2555563</ArticleId></ArticleIdList></Reference><Reference><Citation>Barclay W, Li Q, Hutchinson G, Moon D, Richardson A, Percy N, Almond JW, Evans DJ. 1998. Encapsidation studies of poliovirus subgenomic replicons. J Gen Virol 79:1725–1734. doi:10.1099/0022-1317-79-7-1725</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-79-7-1725</ArticleId><ArticleId IdType="pubmed">9680136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansardi DC, Porter DC, Morrow CD. 1993. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. J Virol 67:3684–3690. doi:10.1128/JVI.67.6.3684-3690.1993</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.67.6.3684-3690.1993</ArticleId><ArticleId IdType="pmc">PMC237726</ArticleId><ArticleId IdType="pubmed">8388519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X-Y, Van Eden M, Busch MG, Ehrenfeld E, Summers DF. 1998. Trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol 72:7972–7977. doi:10.1128/JVI.72.10.7972-7977.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.10.7972-7977.1998</ArticleId><ArticleId IdType="pmc">PMC110132</ArticleId><ArticleId IdType="pubmed">9733835</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Iwai-Itamochi M. 2022. High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test. Sci Rep 12:16074. doi:10.1038/s41598-022-20544-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20544-6</ArticleId><ArticleId IdType="pmc">PMC9514167</ArticleId><ArticleId IdType="pubmed">36167892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent CI, Johnson KL, Sarnow P, Kirkegaard K. 1999. Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol 73:427–435. doi:10.1128/JVI.73.1.427-435.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.1.427-435.1999</ArticleId><ArticleId IdType="pmc">PMC103849</ArticleId><ArticleId IdType="pubmed">9847348</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J, Ooi YS, Wilkinson AW, Peters CE, Foy E, Johnson JR, Zengel J, Ding S, Weng K-F, Laufman O, Jang G, Xu J, Young T, Verschueren E, Kobluk KJ, Elias JE, Sarnow P, Greenberg HB, Hüttenhain R, Nagamine CM, Andino R, Krogan NJ, Gozani O, Carette JE. 2019. Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat Microbiol 4:2523–2537. doi:10.1038/s41564-019-0551-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0551-1</ArticleId><ArticleId IdType="pmc">PMC6879830</ArticleId><ArticleId IdType="pubmed">31527793</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters CE, Schulze-Gahmen U, Eckhardt M, Jang GM, Xu J, Pulido EH, Bardine C, Craik CS, Ott M, Gozani O, Verba KA, Hüttenhain R, Carette JE, Krogan NJ. 2022. Structure-function analysis of enterovirus protease 2A in complex with its essential host factor SETD3. Nat Commun 13:5282. doi:10.1038/s41467-022-32758-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32758-3</ArticleId><ArticleId IdType="pmc">PMC9453702</ArticleId><ArticleId IdType="pubmed">36075902</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MT, Smith M, Carlyle S, Konopka-Anstadt JL, Burns CC, Konz J, Andino R, Macadam A. 2023. Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3. Nature 619:135–142. doi:10.1038/s41586-023-06212-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06212-3</ArticleId><ArticleId IdType="pmc">PMC10322712</ArticleId><ArticleId IdType="pubmed">37316671</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . 2023. Two years since rollout of novel oral polio vaccine type 2 (nOPV2): how’s it all working out?
Available from: https://polioeradicationorg/news-post/two-years-since-rollout-of-novel-oral-polio-vaccine-type-2-nopv2-hows-it-all-working-out</Citation></Reference><Reference><Citation>Arita M, Wakita T, Shimizu H. 2008. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J Gen Virol 89:2518–2530. doi:10.1099/vir.0.2008/002915-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/002915-0</ArticleId><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold J, Andino R. 2000. Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis. J Virol 74:6394–6400. doi:10.1128/jvi.74.14.6394-6400.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.14.6394-6400.2000</ArticleId><ArticleId IdType="pmc">PMC112146</ArticleId><ArticleId IdType="pubmed">10864650</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. 2022. Essential domains of oxysterol-binding protein required for poliovirus replication. Viruses 14:2672. doi:10.3390/v14122672</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122672</ArticleId><ArticleId IdType="pmc">PMC9786093</ArticleId><ArticleId IdType="pubmed">36560676</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. 2008. Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 82:1787–1797. doi:10.1128/JVI.01798-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamentsky L, Jones TR, Fraser A, Bray MA, Logan DJ, Madden KL, Ljosa V, Rueden C, Eliceiri KW, Carpenter AE. 2011. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 27:1179–1180. doi:10.1093/bioinformatics/btr095</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr095</ArticleId><ArticleId IdType="pmc">PMC3072555</ArticleId><ArticleId IdType="pubmed">21349861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>